As HK2 loss could potentially reduce cell malignancy in HNSCC cells, it is expected that HK2-silencing HNSCC cells are less sensitive to PDT treatment (Figure 4B). The gene discussed is HK2; the disease is head and neck squamous cell carcinoma.